Cancer trial aims to cut radiation damage while boosting immune power
NCT ID NCT07188584
Summary
This study is for people newly diagnosed with nasopharyngeal cancer that has spread. It compares two radiation approaches given after chemotherapy and immunotherapy. One approach targets a smaller area to try to reduce side effects and possibly help the immune system work better. The goal is to see if the smaller radiation area is just as good at controlling the cancer while causing fewer problems for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000 Recruiting
RECRUITINGZhuhai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.